Urology Flashcards
(165 cards)
What is acute urinary retention?
Acute urinary retention is a medical emergency marked by the onset of the inability to pass urine over a certain period of time, usually hours to days
Aetiology of acute urinary retention?
BPH
Urethral stricture
Luminal causes; stone, blood clot, tumour, UTI
Mural causes; stricture, neuromuscular dysfunction
Extra-mural; abdominal/ pelvic masses/ tumours, retroperitoneal fibrosis
Neurological pathologies; cauda equina, MS
Obstructive pathologies
Infection
Medication; anticholinergics
Post operative complications
Constipation
Signs and symptoms of acute urinary retention?
Inability to pass urine
Lower abdominal discomfort
Pain or distress
Suprapubic tenderness
Suprapubic mass (due to an enlarged bladder)
Delirium (hypoactive or hyperactive)
Investigations to diagnose acute urinary retention?
Bladder scan/USS renal tract
Digital Rectal Exam
Urinalysis and urine MCS
Evaluation of post-void residual
Bloods tests: FBC, renal profile (renal function is often preserved due to the acuity, unlike in chronic urinary retention), CRP
Consider non-contrast CT KUB if stones suspected
Management of acute urinary retention?
Relieve retention with catheter
Post catheterisation treat the cause
What is balanoposthitis?
Inflammation of the glans of the penis and the prepuce due to infection, dermatological conditions , pre-malignant or malignant conditions
Aetiology of balanoposthitis?
Bacterial infections (e.g., Streptococcus, Staphylococcus)
Fungal infections, predominantly Candida species
Viral infections, such as human papillomavirus (HPV) or herpes simplex virus (HSV)
Dermatological conditions such as psoriasis, lichen planus, or lichen sclerosus
Chemical irritants
Poor hygiene
Phimosis (tight foreskin)
Presentation of balanoposthitis?
Redness and swelling of the glans penis and prepuce
Pain or discomfort
Itching
Presence of a foul-smelling discharge
Difficulty retracting the foreskin (phimosis)
Differentials for balanoposthitis?
Penile carcinoma
Contact dermatitis
Psoriasis
Genital herpes
Genital warts
Lichen sclerosus
Investigations to diagnose balanoposthitis?
Swabs for culture
Skin biopsy
Management of balanoposthitis?
Treat cause; if infectious targetted antibiotics
Avoid irritants like soap or laundry detergent
Keep area dry
What is BPH?
Non cancerous enlargement of the prostate gland (particularly in the transition zone) leading to compression of the urethra and subsequent LUTIS
Epidemiology of BPH?
Highly prevalent among ageing men
By 60 significant proportion exhibit histological evidence of BPH and by 80 nearly 90%
Aetiology of BPH?
Hormonal changes influenced by dihydrotestosterone (DHT) plays role in development
Genetic predisposition and lifestyle factors
Pathophysiology of BPH?
Nodular overgrowth of prostatic tissue predominantly in the transition zone
Growth impinges on the prostatic urethra causing dynamic and static obstruction leading to urinary symptoms
Signs and symptoms of BPH?
Hesitancy
Weak stream
Frequency
Urgency
Nocturia
Sensation of incomplete emptying
Differentials for BPH?
Prostatic cancer
UTI
Neurogenic bladder dysfunction
Urethral stricture
Investigations to diagnose BPH?
International prostate symptom score; used to assess severity of LUTS
Score 20–35: severely symptomatic.
Score 8–19: moderately symptomatic.
Score 0–7: mildly symptomatic.
DRE; assess prostate size, consistency and presence of nodules
PSA test to rule out prostate cancer
NICE guidelines for men presenting with BPH?
Refer men using a suspected cancer pathway referral for prostate cancer if their prostate feels malignant on DRE.
Consider a PSA and DRE to assess for prostate cancer in men with:
Any lower urinary tract symptoms, such as nocturia, urinary frequency, hesitancy, urgency or retention, or
Erectile dysfunction, or
Visible haematuria.
Refer men using a suspected cancer pathway referral (for an appointment within 2 weeks) for prostate cancer if their PSA levels are above the age-specific reference range.
Management of BPH?
Watchful waiting
Lifestyle modification; Fluid restriction, avoid caffeine and alcohol, timed voiding
Medical therapy;
Alpha blockers; tamsulosin
5 alpha reductase inhibitors; finasteride
TURP
Proctectomy
What is bladder cancer?
Malignant growth within urinary bladder
Epidemiology of bladder cancer?
11th most common cancer in UK
In developed countries 90% of bladder cancer is transitional cell carcinoma with majority of remaining cases being squamous cell carcinomas
Risk factors for bladder cancer?
Transitional cell carcinoma;
Smoking
Exposure to aromatic amines (employed in rubber, dyes, and chemical industry)
Use of Cyclophosphamide
Squamous cell carcinoma;
Schistosomiasis infection
Long-term catheterisation (10+ years)
Adenocarcinoma
Presence of other types of bladder cancer
Local bowel cancer
Types of bladder cancer?
Transitional cell carcinoma
Squamous cell carcinoma
Adenocarcinoma
Small cell bladder cancer